Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 96 clinical trials
Ruxolitinib for Adult T-Cell Leukemia

>Ruxolitinib is a drug that has been approved to treat bone marrow disorders. It can interfere with the proteins that are important to the development and growth of ATL cells. Drugs like ruxolitinib may be

  • 7 views
  • 12 Sep, 2021
  • 1 location
Topical Ruxolitinib for Cutaneous Chronic Graft Versus Host Disease (cGVHD)

ruxolitinib inhibits proteins that may play a role in cGVHD. Objective To test the safety and effectiveness of topical ruxolitinib 1.5 percent cream in people with cGVHD

neutrophil count
immunosuppressive agents
extracorporeal photopheresis
cancer
ruxolitinib
  • 32 views
  • 17 Sep, 2021
  • 1 location
Nivolumab With Ruxolitinib in Relapsed or Refractory Classical Hodgkin Lymphoma

This is a Phase I/II, multicenter, open-label, dose escalation/dose-expansion study to evaluate the tolerability, safety, and the maximum tolerated dose (MTD) of ruxolitinib when given with

measurable disease
classical hodgkin lymphoma
nivolumab
cancer
lymphoma
  • 39 views
  • 25 Aug, 2021
  • 4 locations
Jaktinib Hydrochloride for the Treatment of Ruxolitinib Intolerance of Myelofibrosis

With Ruxolitinib. The experiment is divided into two parts: dose exploration and extended research.

neutrophil count
polycythemia
extramedullary hematopoiesis
essential thrombocythemia
anemia
  • 18 views
  • 24 Jun, 2021
  • 1 location
Ruxolitinib and Decitabine for High Risk Hematological Malignancies

The purpose of this study is to determine the efficacy and safety of Ruxolitinib and Decitabine intensified Conditioning Regimen in Patients with High Risk hematological malignancies undergoing

  • 0 views
  • 25 Jan, 2021
  • 1 location
A Study of Ruxolitinib and Duvelisib in People With Lymphoma

This study will test the safety of ruxolitinib, given at one dose that does not change, and duvelisib, given at different doses, to find out what effects, if any, the study treatment has on

neutrophil count
anaplastic large cell lymphoma
measurable disease
t-cell prolymphocytic leukemia
large cell lymphoma
  • 0 views
  • 29 Aug, 2021
  • 7 locations
Ruxolitinib for Early Lung Dysfunction After Hematopoietic Stem Cell Transplant

fibrosis has occurred and lesions are irreversible. The hypothesis for this interventional trial is that early treatment with standard Flovent/montelukast and steroids plus ruxolitinib will reverse

  • 0 views
  • 26 Jul, 2021
  • 1 location
A Clinical Study to Test the Effects of Ruxolitinib And Thalidomide Combination for Patients With Myelofibrosis

The purpose of this study is to test any good and bad effects of the study drugs called ruxolitinib and thalidomide. Ruxolitinib and thalidomide could shrink the cancer, but it could also cause

polycythemia
ruxolitinib
cancer
  • 198 views
  • 03 Feb, 2021
  • 8 locations
Ruxolitinib for Bronchiolitis Obliterans Syndrome (BOS) After Allogeneic Hematopoietic Cell Transplantation (HCT)

This research study is studying a drug as a possible treatment for Bronchiolitis Obliterans Syndrome (BOS) after having an Allogeneic Hematopoietic Cell Transplantation (HCT).

  • 1 views
  • 26 Jan, 2021
Ruxolitinib With Radiation and Temozolomide for Grade III Gliomas and Glioblastoma

The purpose of this study is to test how well the drug works, safety and tolerability of an investigational drug called Ruxolitinib in gliomas and glioblastomas, when combined with standard

malignant glioma
MRI
methylated
astrocytoma, anaplastic
glioblastoma multiforme
  • 31 views
  • 12 Jun, 2021
  • 2 locations